• Profile
Close

One-year retention study of adjunctive perampanel treatment in epilepsy patients

Clinical Neuropharmacology Jan 24, 2018

Kim DW, et al. - A retrospective analysis of retention rate, seizure outcome, and adverse events for perampanel treatment was performed among epilepsy patients in South Korea. For adjunctive perampanel treatment, the retention rate and adverse events in the Korean population were similar with those in Western countries. Moreover, findings suggested that in patients taking a higher number of concomitant antiepileptic drugs (AEDs), adjuvant perampanel treatment could be effective and that psychiatric comorbidity might be a risk factor for perampanel-induced psychiatric reactions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay